Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-kynurenine hemodynamic effects in healthy volunteers
NCT03212430Phase 1Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Mar 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of l-kynurenine in stroke and epilepsy, sponsored by Dansk Hovedpinecenter. Primary endpoints: Velocity of Middle Cerebral Artery at 2 hours, Diameter of the Superficial Temporal Artery at 2 hours and 1 more. Started Mar 2017; status: completed.
02
Drugs
l-kynurenine
03
Conditions
strokeepilepsy
Beyond the preview
Go deeper on NCT03212430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03212430.